ロード中...
Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
Epigenetic therapy with hypomethylating agent (5-azacytidine; AZA) is common in the management of specific subtypes of myelodysplastic syndrome (MDS), but there are only few studies in chronic myelomonocytic leukemia (CMML) patients. In this paper our experience with 3 CMML patients treated with AZA...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3420792/ https://ncbi.nlm.nih.gov/pubmed/22937326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/369086 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|